default author photo

JuanJuan Su

- Division of Immunotherapy

SCHOLARLY PAPERS

1

DOWNLOADS

27

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Targeting HIF1α in Bone Marrow Transplant Allows Combo-Immunotherapy to Boost Graft vs Leukemia Effect Without Exacerbation Graft vs Host Disease

Number of pages: 63 Posted: 29 Apr 2023
- Division of Immunotherapy, - Division of Immunotherapy, Dalian Medical University - Department of Hematology, Dalian Medical University - Department of Hematology, Capital Medical University - Department of Neurosurgery, Jilin University (JLU) - Institute of Translational Medicine, Children's National Hospital - Center for Cancer and Immunology Research, - Division of Immunotherapy, - Division of Immunotherapy, Children's National Hospital - Center for Cancer and Immunology Research, - Division of Immunotherapy, - Division of Immunotherapy, - Division of Immunotherapy and - Division of Immunotherapy
Downloads 27 (1,358,653)

Abstract:

Loading...

immunotherapy-related adverse events, hypoxia-inducible factor 1α, graft-versushost disease, graft-versus-leukemia, programmed death ligand 1, Cytotoxic T-Lymphocyte